BridgeBio Pharma (BBIO) Earnings Date & Reports

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BBIO is expected to report earnings to fall 28.82% to -59 cents per share on July 30

BridgeBio Pharma BBIO Stock Earnings Reports

Q2'26

Est.

$-0.60

Q1'26

Missed

by $0.16

Q4'25

Missed

by $0.28

Q3'25

Missed

by $0.07

Q2'25

Missed

by $0.20

The last earnings report on May 07 showed earnings per share of -83 cents, missing the estimate of -68 cents. With 2.07M shares outstanding, the current market capitalization sits at 16.27B.

View a ticker or compare two or three

Compare

BBIO

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for BBIO